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The current study from Eslami et al has used the American College of Surgeons National Surgical Quality Improvement Project (ACS-NSQIP) to identify a risk prediction model for 30-day mortality after abdominal aortic aneurysm (AAA) repair by an open or endovascular approach. The model they developed showed that cardiac, pulmonary, and renal disease, in addition to age, functional dependence, American Society of Anesthesiologists class, gender, and modality of repair were all associated with higher 30-day mortality.
The use of "big data" has permitted investigators to predict rare events and evaluate rare covariates with outcomes of interest. However, the use of secondary data to test a research hypothesis carries important considerations. How were the data collected, and for what purpose? Did the data set contain important covariates known to be associated with the outcome? Is the chosen outcome appropriate and clinically useful?
In clinical practice, patients are counseled about their annual AAA rupture risk. A 30-day or in-hospital mortality risk does not capture later death, which is also an important consideration in the decision to proceed with aneurysm repair. Specific risk factors may assess 1-year mortality risk and be more helpful in contrasting annual rupture risk vs repair risk at 1 year, as opposed to 30-day outcomes alone.
1,2 ACS-NSQIP is limited to only 30-day events.
With the addition of this model, there are no fewer than five risk-prediction models for perioperative mortality after AAA repair. [3] [4] [5] [6] The ability of these models to discriminate risk, measured by the area under the receiver operating characteristic curve, ranges from 0.70 to 0.82. Although this is a fair degree of discrimination, a significant portion of the variation in death is left unexplained. Many risk-prediction models do not calibrate risk appropriately for patients at very low or very high risk. Although this study appears to calibrate well to a 6% mortality risk, whether that degree of calibration holds for higher predicted death risks is unclear. Overall, the current risk model appears to perform in a fashion similar to other available models. This may be due to the lack of important variables in ACS-NSQIP (ie, aneurysm size) or development of the model to be simplified (converting age to a dichotomous variable). Robust risk-prediction models with improved discrimination and calibration must identify those factors unaccounted for in our current data sets, potentially incorporating measures of frailty. In addition, models that evaluate late mortality are of equal importance to ensure optimal patient selection for AAA repair.
